While various methods are discussed, this course's primary focus is immunohistochemical (IHC) staining and fluorescence in situ hybridization (FISH) testing for HER2. All recommendations are based on the current 2018 and 2023 American Society of Clinical Oncology (ASCO)–College of American Pathologists (CAP) HER2 Test Guideline Recommendations.
